Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis.
Taban
Mehran
M
Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Lowder
Careen Y
CY
Kaiser
Peter K
PK
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002387:Cataract Extraction; D002908:Chronic Disease; D004343:Drug Implants / Q000009:adverse effects; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage* / Q000009:adverse effects; D005500:Follow-Up Studies; D005901:Glaucoma / Q000139:chemically induced / Q000601:surgery; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012163:Retinal Detachment / Q000209:etiology / Q000601:surgery; D012167:Retinal Perforations / Q000139:chemically induced / Q000150:complications; D019233:Retreatment; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D015866:Uveitis, Posterior / Q000188:drug therapy* / Q000503:physiopathology; D014792:Visual Acuity / Q000187:drug effects; D014823:Vitreous Hemorrhage / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D004343:Drug Implants; D005446:Fluocinolone Acetonide